Research Progress on the Experimental Model and Underlying Mechanistic Studies of Tension-Type Headaches
- PMID: 38502437
- PMCID: PMC11126509
- DOI: 10.1007/s11916-024-01238-2
Research Progress on the Experimental Model and Underlying Mechanistic Studies of Tension-Type Headaches
Abstract
Purpose of review: Tension-type headaches (TTH) significantly diminish patients' quality of life and increase absenteeism, thereby imposing a substantial economic burden. Animal models are essential tools for studying disease mechanisms and drug development. However, until now, little focus has been placed on summarizing the animal models of TTH and associated mechanistic studies. This narrative review discusses the current animal models of TTH and related mechanistic studies to provide insights into the pathophysiological mechanisms of and treatments for TTH.
Recent findings: The primary method for constructing an animal model of TTH involves injecting a solution of pain relievers, such as adenosine triphosphate, nerve growth factor, or a high concentration of salt solution, into the neck to initiate harmful cervical muscle responses. This model enables the examination of the interaction between peripheral muscles and central sensitization, which is crucial for understanding the pathophysiology of TTH. Mechanistic studies based on this model have investigated the effect of the P2X receptor antagonist, P2X7 receptor blockade, the P2Y1 receptor agonist 2-MESADP, P2Y1 receptor antagonist MRS2179, nitric oxide synthase inhibitors, and acetylsalicylic acid. Despite notable advancements, the current model of TTH has limitations, including surgical complexity and the inability to replicate chronic tension-type headache (CTTH). To gain a more comprehensive understanding and develop more effective treatment methods, future studies should focus on simplifying surgical procedures, examining other predisposing factors, and establishing a model for chronic TTH. This will offer a deeper insight into the pathophysiological mechanism of TTH and pave the way for improved treatment approaches.
Keywords: Adenosine triphosphate; Animal model; Nerve growth factor; Pathophysiology; Tension-type headache.
© 2024. The Author(s).
Conflict of interest statement
The authors declare no conflict of interest.
Figures
![Fig. 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/11126509/bin/11916_2024_1238_Fig1_HTML.gif)
Similar articles
-
[Tension-type headache].Rev Neurol (Paris). 2005 Jul;161(6-7):720-2. doi: 10.1016/s0035-3787(05)85128-8. Rev Neurol (Paris). 2005. PMID: 16141970 Review. French.
-
Pain perception studies in tension-type headache.Headache. 2011 Feb;51(2):262-71. doi: 10.1111/j.1526-4610.2010.01768.x. Epub 2010 Oct 1. Headache. 2011. PMID: 21029081 Review.
-
Advances in the Understanding of Pathophysiology of TTH and its Management.Neurol India. 2021 Mar-Apr;69(Supplement):S116-S123. doi: 10.4103/0028-3886.315986. Neurol India. 2021. PMID: 34003157 Review.
-
Tension-type headache: current research and clinical management.Lancet Neurol. 2008 Jan;7(1):70-83. doi: 10.1016/S1474-4422(07)70325-3. Lancet Neurol. 2008. PMID: 18093564 Review.
-
Advances in the pathophysiology of tension-type headache: from stress to central sensitization.Curr Pain Headache Rep. 2009 Dec;13(6):484-94. doi: 10.1007/s11916-009-0078-x. Curr Pain Headache Rep. 2009. PMID: 19889292 Review.
References
-
- • Collaborators GH. Global, regional, and national burden of migraine and tension-type headache, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2018;17:954–976. This article provides an overview of the GBD methods as applied to headache, to present detailed results of the update for 1990–2016 on headache burden in different world regions and with time trends, and to discuss the implications of these results both for future iterations of GBD and for health policies around the world.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials